Science Community Is Mixed On Clinton's Economic Plan

While some experts see virtue in the new president's technology policy, others warn of hidden probems High-technology company executives and association officials, along with leading scientists and others in the United States research and development community, are largely upbeat in their initial responses to President Bill Clinton's economic program and his ambitious effort to redirect U.S. technology policy. At the same time, several science and technology policy-watchers interviewed by Th

Written byBarton Reppert
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

High-technology company executives and association officials, along with leading scientists and others in the United States research and development community, are largely upbeat in their initial responses to President Bill Clinton's economic program and his ambitious effort to redirect U.S. technology policy. At the same time, several science and technology policy-watchers interviewed by The Scientist say they will need further details about the administration's science and technology initiatives, including specific budget figures, before they can offer a more thorough assessment of the Clinton plan.

The Clinton administration has proposed the following new initiatives in its technology policy, as presented in a White House policy paper, "Technology for America's Economic Growth" (released on February 22): Research and Experimentation Tax Credit: The administration is calling for permanent extension of this tax credit, which would apply to qualified research expenditures paid or incurred after June 30, 1992. Information Infrastructure: Includes implementing the High- ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies